Progression to AIDS slowed even more after the first two years with highly active antiretroviral therapy
- 1 August 2003
- journal article
- other
- Published by SAGE Publications in Scandinavian Journal of Public Health
- Vol. 31 (4) , 312-318
- https://doi.org/10.1080/14034940210165000
Abstract
Aims: The aim of this study was to describe the effectiveness of highly active antiretroviral treatment for HIV after the treatment became publicly available in Norway in August 1996 and through to the year 2000. The effectiveness was studied for the three main transmission groups for HIV in Norway. Methods: Effectiveness was measured as change in progression to AIDS after highly active antiretroviral treatment for HIV was introduced in the population of HIV-diagnosed persons. Notifications of HIV diagnosed persons and persons with AIDS from 1983 to 2000 in Norway were used in the analysis. Progression to AIDS after August 1996 compared with progression to AIDS before 1996 was analysed by Kaplan-Meier curves and Cox regression models. Results: Progression to AIDS slowed after highly active antiretroviral treatment was introduced. The intensity of getting AIDS was significantly reduced after August 1996 compared with the intensity of getting AIDS before August 1996. The reduction in intensity after August 1996 was less explicit in the two years following August 1996 than in the subsequent two and a half years from August 1998 to December 2000. The reduction was less explicit among HIV-diagnosed intravenous drug users. Conclusions: The effectiveness of highly active antiretroviral treatment lasted for at least four and a half years and increased after the first two calendar years. The problem of less effectiveness among HIV-diagnosed intravenous drug users should be addressed by the health authorities.Keywords
This publication has 12 references indexed in Scilit:
- Effect of combination therapy on immunologic progression of human immunodeficiency virus at a population level.American Journal of Epidemiology, 2001
- Anonymous reporting of HIV infection: An evaluation of the HIV/AIDS surveillance system in Norway 1983–2000European Journal of Epidemiology, 2001
- A review of antiretroviral drugsDermatologic Therapy, 2000
- Hit HIV-1 hard, but only when necessaryThe Lancet, 2000
- Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection DurationJAMA, 1998
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trialThe Lancet, 1997
- Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatmentsAIDS, 1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958